These Form 3 filings confirm that Attovia Therapeutics has completed or is imminently completing its IPO. Monitor the IPO pricing and first-day trading for price discovery. The large insider stakes (Vida and venBio) suggest long-term alignment, but lock-up expiration dates (not disclosed) will be a key future catalyst for potential selling pressure.
Price Chart
Executive Summary
Multiple Form 3 initial beneficial ownership filings were filed on August 4, 2026, by major pre-IPO investors (Vida Ventures entities and venBio Global Strategic Fund IV) and director Angie You, disclosing their equity stakes in Attovia Therapeutics. These filings are routine post-IPO ownership disclosures triggered by the company's recent initial public offering, as evidenced by references to automatic conversion of preferred stock upon IPO closing and a 1-for-9.29 reverse stock split effected on July 29, 2026.
Key Facts
- Vida Ventures III, L.P. beneficially owns 937,265 shares of common stock (held indirectly).
- Vida Ventures III-A, L.P. beneficially owns 2,160 shares of common stock (held indirectly).
- venBio Global Strategic Fund IV, L.P. beneficially owns common stock equivalents: 2,311,870 from Series A Preferred, 821,998 from Series B Preferred, and 665,147 from Series C Preferred (total ~3.8M shares).
- Director Angie You directly owns 52,852 shares of common stock and holds options to purchase 19,913 shares at $4.9237 per share, expiring May 17, 2035.
- All preferred stock automatically converts to common stock upon closing of the IPO (Series C at 9.29-for-1; Series A/B/C at 1-for-1 after reverse split).
- A 1-for-9.29 reverse stock split was effected on July 29, 2026, ahead of the IPO.
Financial Impact
No financial figures disclosed; filings confirm insider ownership stakes post-IPO.
Risk Factors
- Insider lock-up agreements typical in IPOs may restrict selling for 90-180 days; post-lock-up selling could pressure the stock.
- No financial performance data is provided in these filings; fundamental valuation depends on the company's pipeline and revenue prospects.
Investment Themes
Documents Analyzed
This report is based on 24 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (ATTO) — Batch item 1 | 0001193125-26-333417 |
| Document: 0001193125-26-333417-index.html | 0000905148-26-003465 |
| Document: 0001193125-26-333417.txt | 0001193125-26-333385 |
| 3 Filing (ATTO) — Batch item 4 | 0000905148-26-003465 |
| Document: poa_gaster.htm | 0000905148-26-003465 |
| Document: 0000905148-26-003465-index-headers.html | 0001193125-26-333385 |
| Document: 0000905148-26-003465-index.html | 0001193125-26-333417 |
| Document: 0000905148-26-003465.txt | 0001193125-26-333417 |
| 3 Filing (ATTO) — Batch item 9 | 0001193125-26-333385 |
| Document: 0001193125-26-333385-index-headers.html | 0001193125-26-333417 |
| Document: 0001193125-26-333385-index.html | 0001193125-26-333417 |
| Document: 0001193125-26-333385.txt | 0001193125-26-333417 |
| 3 Filing (ATTO) — Batch item 13 | 0001193125-26-333417 |
| Document: 0001193125-26-333417-index.html | 0001193125-26-333417 |
| Document: 0001193125-26-333417.txt | 0001193125-26-333417 |
| 3 Filing (ATTO) — Batch item 16 | 0000905148-26-003465 |
| Document: poa_gaster.htm | 0001193125-26-333417 |
| Document: 0000905148-26-003465-index-headers.html | 0001193125-26-333417 |
| Document: 0000905148-26-003465-index.html | 0001193125-26-333417 |
| Document: 0000905148-26-003465.txt | 0001193125-26-333417 |
| 3 Filing (ATTO) — Batch item 21 | 0001193125-26-333385 |
| Document: 0001193125-26-333385-index-headers.html | 0001193125-26-333417 |
| Document: 0001193125-26-333385-index.html | 0001193125-26-333417 |
| Document: 0001193125-26-333385.txt | 0001193125-26-333417 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 18d ago | 3/A | $16.21 | awaiting T+20 | — | $13.88 (−14.37%) |
Oct 8, 2026 18d ago | 3/A | $16.21 | awaiting T+20 | — | $13.88 (−14.37%) |
Sep 28, 2026 28d ago | Press Release | $18.16 | awaiting T+20 | — | $13.88 (−23.57%) |
Sep 2, 2026 7w ago | Press Release | $24.20 $17.14 | ▼ −29.17% | ▼ −28.06% | $13.88 (−42.64%) |
Aug 28, 2026 8w ago | 144 / CLUSTER | $21.40 $18.16 | ▼ −15.14% | ▼ −14.95% | $13.88 (−35.14%) |
Aug 13, 2026 10w ago | Insider Buy | $19.86 $24.52 | ▲ +23.46% | ▲ +25.46% | $13.88 (−30.11%) |
Aug 13, 2026 10w ago | Insider Cluster | $19.86 $24.52 | ▲ +23.46% | ▲ +25.46% | $13.88 (−30.11%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.65 $22.86 | ▲ +22.57% | ▲ +23.63% | $13.88 (−25.58%) |
Aug 7, 2026 11w ago | Insider Cluster | $19.84 $23.66 | ▲ +19.25% | ▲ +20.17% | $13.88 (−30.04%) |
Aug 7, 2026 11w ago | Insider Cluster | $20.17 $25.55 | ▲ +26.67% | ▲ +27.07% | $13.88 (−31.18%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers